Modified Bacteria Deliver Cancer Treatment Directly to Tumors
What Happened
Researchers have engineered probiotic bacteria to produce anti-cancer drugs directly inside tumors. The modified microbes are designed to selectively grow within tumors and generate therapeutic compounds locally, potentially improving drug delivery while reducing damage to healthy tissues. The approach aims to concentrate treatment exactly where it is needed instead of relying solely on drugs circulating throughout the body.
Key Takeaways
The research highlights a promising new direction in cancer treatment, where engineered bacteria act as "living drug factories" inside tumors. If proven successful in further studies and clinical trials, the technology could help make cancer therapies more targeted, effective and potentially less toxic for patients.